对亚托邦性皮肤炎的治疗方法
1Royal Melbourne Hospital, East Malvern Dermatology, Melbourne.
Australian prescriber
|December 6, 2023
概括
亚托皮炎的管理包括非药物和药物治疗,以清除皮肤. 识别和避免触发因素,以及持续保湿,是管理这种常见皮肤疾病的关键.
科学领域:
- 皮肤病学 皮肤病学
- 免疫学 免疫学 免疫学
- 过敏 过敏是一种过敏.
背景情况:
- 亚托皮炎 (AD) 是一种慢性炎症性皮肤疾病,通常从童年开始,但也会影响成年人.
- 虽然过敏很常见,但并非所有阿尔茨海默病患者都有过敏;对于许多人来说,避免触发因素至关重要.
- 有效的管理旨在皮肤清除和缓解症状.
研究的目的:
- 概述目前对亚托皮性皮肤炎的管理策略.
- 详细介绍各种治疗方案,从基本的护肤到先进的全身疗法.
- 强调基于疾病严重程度和受影响区域的个性化治疗的重要性.
主要方法:
- 审查已建立和新兴的治疗方法对亚托邦性皮肤炎.
- 讨论非药物干预措施,包括皮肤护理和触发器避免.
- 药理疗法的概述:局部皮质类固醇,氨酸抑制剂,抗胰岛素,光疗和全身性药物.
主要成果:
- 基本的皮肤护理 (肥替代品,浴油,保湿剂) 对所有患者来说都是基本的.
- 局部皮质类固醇是主要的药物治疗,选择取决于受影响的部位.
- 像漂白浴,湿,光疗和全身药物 (免疫抑制剂,dupilumab,upadacitinib) 等先进疗法可用于严重或耐火病例.
结论:
- 对亚托皮性皮炎的综合管理需要采用多方面的方法.
- 根据患者个体需求量身定制治疗方法,包括触发因素的识别和适当的药物选择,至关重要.
- 新的全身疗法为严重和慢性亚托皮性皮肤炎提供了改进的选择.
相关概念视频
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
305
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
305
01:19Antiasthma Drugs: Leukotriene Modifiers
320
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
320
01:29Inflammatory Bowel Disease IV: Pharmacological Management
130
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
130
01:30Hypersensitivities
676
Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
676
01:30Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
121
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
121